Editorial: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have potential to transform health outcomes for persons with bipolar disorder, schizophrenia, major depressive disorder and other serious mental illnesses by lengthening healthspan and reducing excess and premature mortality
Discontinuation of NSAID therapy is usually followed by the recovery to the clinical status and laboratory values of the pretreatment state
Our approach follows the Blue Horizon Method: a calm, clinically responsible journey that starts with your GP, incorporates careful self-tracking, and uses structured blood testing to provide a snapshot for better-informed professional conversations
Despite encouraging data, no clinical series have been published to date on the effectiveness of radiotherapy, and no treatment protocol is available
Leaving before the feedback session means missing the most valuable part of the process
10.1007/s40263-017-0479-z 28 NakajimaY.ItoT.MaedaY.IchikiS.KobayashiS.AndoN.et al (2011)
